XIAP and myalgic encephalomeyelitis/chronic fatigue syndrome: In addition to potential biomarker value, the understanding of the mechanisms leading to increased XIAP in ME/CFS, either due by activation of TTMV or not, suggests the potential benefit of embelin, a plant-derived benzoquinone with anti-oxidant and anti-inflammatory properties targeting XIAP [49].